Rossini R - Search Results

1

Effects Of Glycoprotein IIb/IIIa Antagonists: Anti Platelet Aggregation And Beyond.

Giordano A, Musumeci G, D'Angelillo A, Rossini R, Zoccai GB, Messina S, Coscioni E, Romano S, Romano MF. Giordano A, et al. Among authors: rossini r. Curr Drug Metab. 2016;17(2):194-203. doi: 10.2174/1389200217666151211121112. Curr Drug Metab. 2016. PMID: 26652157 Review.

2

Antiplatelet therapy in patients undergoing coronary stent implantation: Italian Society of Interventional Cardiology consensus document.

Guagliumi G, Musumeci G, Rossini R, Bolognese L, Giordano A, Marzocchi A, Ramondo A, Sangiorgi G, Tamburino C, Tomai F, De Servi S. Guagliumi G, et al. Among authors: rossini r. J Cardiovasc Med (Hagerstown). 2007 Oct;8(10):782-91. doi: 10.2459/JCM.0b013e3282785250. J Cardiovasc Med (Hagerstown). 2007. PMID: 17885515 Review.

3

Aspirin desensitization in patients undergoing percutaneous coronary interventions with stent implantation.

Rossini R, Angiolillo DJ, Musumeci G, Scuri P, Invernizzi P, Bass TA, Mihalcsik L, Gavazzi A. Rossini R, et al. Am J Cardiol. 2008 Mar 15;101(6):786-9. doi: 10.1016/j.amjcard.2007.10.045. Epub 2008 Feb 21. Am J Cardiol. 2008. PMID: 18328841

4

Long-term outcomes in patients undergoing coronary stenting on dual oral antiplatelet treatment requiring oral anticoagulant therapy.

Rossini R, Musumeci G, Lettieri C, Molfese M, Mihalcsik L, Mantovani P, Sirbu V, Bass TA, Della Rovere F, Gavazzi A, Angiolillo DJ. Rossini R, et al. Am J Cardiol. 2008 Dec 15;102(12):1618-23. doi: 10.1016/j.amjcard.2008.08.021. Epub 2008 Sep 24. Am J Cardiol. 2008. PMID: 19064015

5

Long-term outcomes in patients undergoing percutaneous coronary intervention with drug-eluting stents.

Rossini R, Musumeci G, Aprile A, Valsecchi O. Rossini R, et al. Expert Rev Pharmacoecon Outcomes Res. 2010 Feb;10(1):49-61. doi: 10.1586/erp.10.1. Expert Rev Pharmacoecon Outcomes Res. 2010. PMID: 20121564 Review.

6

Prevention of left ventricular remodelling after acute myocardial infarction: an update.

Rossini R, Senni M, Musumeci G, Ferrazzi P, Gavazzi A. Rossini R, et al. Recent Pat Cardiovasc Drug Discov. 2010 Nov;5(3):196-207. doi: 10.2174/157489010793351999. Recent Pat Cardiovasc Drug Discov. 2010. PMID: 20874671 Review.

7

Safety of clopidogrel and proton pump inhibitors in patients undergoing drug-eluting stent implantation.

Rossini R, Capodanno D, Musumeci G, Lettieri C, Lortkipanidze N, Romano M, Nijaradze T, Tarantini G, Cicorella N, Sirbu V, Guagliumi G, Rosiello R, Valsecchi O, Gavazzi A. Rossini R, et al. Coron Artery Dis. 2011 May;22(3):199-205. doi: 10.1097/MCA.0b013e328343b03a. Coron Artery Dis. 2011. PMID: 21358542

8

Prognostic implications of early and long-term bleeding events in patients on one-year dual antiplatelet therapy following drug-eluting stent implantation.

Musumeci G, Rossini R, Lettieri C, Capodanno D, Romano M, Rosiello R, Guagliumi G, Valsecchi O, Gavazzi A, Angiolillo DJ. Musumeci G, et al. Among authors: rossini r. Catheter Cardiovasc Interv. 2012 Sep 1;80(3):395-405. doi: 10.1002/ccd.23337. Epub 2012 Jan 10. Catheter Cardiovasc Interv. 2012. PMID: 22109961

9

GP IIb/IIIa inhibitors for STEMI: still the gold standard or an old survivor?

Musumeci G, Baroni M, Rossini R. Musumeci G, et al. Among authors: rossini r. Curr Vasc Pharmacol. 2012 Jul;10(4):443-7. doi: 10.2174/157016112800812737. Curr Vasc Pharmacol. 2012. PMID: 22339252 Review.

10

Oral antiplatelet therapy after drug-eluting stent implantation: adherence and side-effects.

Rossini R, Baroni M, Musumeci G, Gavazzi A. Rossini R, et al. J Cardiovasc Med (Hagerstown). 2013 Feb;14(2):81-90. doi: 10.2459/JCM.0b013e328356a545. J Cardiovasc Med (Hagerstown). 2013. PMID: 22885533

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

270 results

Search Page